WallStSmart

Genenta Science SpA ADR (GNTA)vsHoneywell International Inc (HON)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

HON leads profitability with a 21.6% profit margin vs 0.0%. HON earns a higher WallStSmart Score of 71/100 (B).

GNTA

Avoid

23

out of 100

Grade: F

Growth: 4.3Profit: 3.0Value: 5.0Quality: 6.0
Piotroski: 3/9Altman Z: -1.00

HON

Strong Buy

71

out of 100

Grade: B

Growth: 6.0Profit: 8.0Value: 4.7Quality: 5.5
Piotroski: 4/9Altman Z: 2.05
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for GNTA.

HONSignificantly Overvalued (-28.6%)

Margin of Safety

-28.6%

Fair Value

$189.42

Current Price

$222.14

$32.72 premium

UndervaluedFair: $189.42Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

GNTA1 strengths · Avg: 10.0/10
Price/BookValuation
0.6x10/10

Reasonable price relative to book value

HON6 strengths · Avg: 9.3/10
P/E RatioValuation
7.8x10/10

Attractively priced relative to earnings

Return on EquityProfitability
31.1%10/10

Every $100 of equity generates 31 in profit

EPS GrowthGrowth
263.9%10/10

Earnings expanding 263.9% YoY

Market CapQuality
$67.00B9/10

Large-cap with strong market position

Profit MarginProfitability
21.6%9/10

Keeps 22 of every $100 in revenue as profit

Operating MarginProfitability
20.3%8/10

Strong operational efficiency at 20.3%

Areas to Watch

GNTA4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$30.38M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

HON2 concerns · Avg: 3.0/10
Revenue GrowthGrowth
4.3%4/10

4.3% revenue growth

PEG RatioValuation
3.472/10

Expensive relative to growth rate

Comparative Analysis Report

WallStSmart Research

Bull Case : GNTA

The strongest argument for GNTA centers on Price/Book.

Bull Case : HON

The strongest argument for HON centers on P/E Ratio, Return on Equity, EPS Growth. Profitability is solid with margins at 21.6% and operating margin at 20.3%.

Bear Case : GNTA

The primary concerns for GNTA are Revenue Growth, EPS Growth, Market Cap.

Bear Case : HON

The primary concerns for HON are Revenue Growth, PEG Ratio.

Key Dynamics to Monitor

HON carries more volatility with a beta of 0.89 — expect wider price swings.

HON is growing revenue faster at 4.3% — sustainability is the question.

HON generates stronger free cash flow (137M), providing more financial flexibility.

Monitor CONGLOMERATES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

HON scores higher overall (71/100 vs 23/100), backed by strong 21.6% margins. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Genenta Science SpA ADR

INDUSTRIALS · CONGLOMERATES · USA

Genenta Science SpA, a clinical-stage biotechnology company, is dedicated to the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. The company is headquartered in Milan, Italy.

Visit Website →

Honeywell International Inc

INDUSTRIALS · CONGLOMERATES · USA

Honeywell International Inc. is an American publicly traded, multinational conglomerate headquartered in Charlotte, North Carolina. It primarily operates in four areas of business: aerospace, building technologies, performance materials and technologies (PMT), and safety and productivity solutions (SPS).

Want to dig deeper into these stocks?